Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells.

Caulier A, Jankovsky N, Demont Y, Ouled-Haddou H, Demagny J, Guitton C, Merlusca L, Lebon D, Vong P, Aubry A, Lahary A, Rose C, Gréaume S, Cardon E, Platon J, Ouadid-Ahidouch H, Rochette J, Marolleau JP, Picard V, Garçon L.

Haematologica. 2020 Mar;105(3):610-622. doi: 10.3324/haematol.2019.218503. Epub 2019 Aug 14.

2.

DHEA prevents ribavirin-induced anemia via inhibition of glucose-6-phosphate dehydrogenase.

Handala L, Domange B, Ouled-Haddou H, Garçon L, Nguyen-Khac E, Helle F, Bodeau S, Duverlie G, Brochot E.

Antiviral Res. 2017 Oct;146:153-160. doi: 10.1016/j.antiviral.2017.09.002. Epub 2017 Sep 8.

PMID:
28890388
3.

A somatic mosaicism in the G6PD gene inducing a late onset chronic non-spherocytic hemolytic anemia.

Couronné L, Tertian G, Boutron A, Picard V, Ouled-Haddou H, Hughes P, Hermine O, Préhu C, Tchernia G, Garçon L.

Am J Hematol. 2017 Aug;92(8):E153-E155. doi: 10.1002/ajh.24760. Epub 2017 Jun 1. No abstract available.

4.

Hepatocyte SLAMF3 reduced specifically the multidrugs resistance protein MRP-1 and increases HCC cells sensitization to anti-cancer drugs.

Fouquet G, Debuysscher V, Ouled-Haddou H, Eugenio MS, Demey B, Singh AR, Ossart C, Al Bagami M, Regimbeau JM, Nguyen-Khac E, Naassila M, Marcq I, Bouhlal H.

Oncotarget. 2016 May 31;7(22):32493-503. doi: 10.18632/oncotarget.8679.

5.

RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation.

Bouhlal H, Ouled-Haddou H, Debuysscher V, Singh AR, Ossart C, Reignier A, Hocini H, Fouquet G, Al Baghami M, Eugenio MS, Nguyen-Khac E, Regimbeau JM, Marcq I.

Oncotarget. 2016 Mar 1;7(9):9832-43. doi: 10.18632/oncotarget.6954.

6.

Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells.

Ghamlouch H, Darwiche W, Hodroge A, Ouled-Haddou H, Dupont S, Singh AR, Guignant C, Trudel S, Royer B, Gubler B, Marolleau JP.

Oncotarget. 2015 Jul 30;6(21):18484-503.

7.

TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting Cells.

Ghamlouch H, Ouled-Haddou H, Guyart A, Regnier A, Trudel S, Claisse JF, Fuentes V, Royer B, Marolleau JP, Gubler B.

Front Immunol. 2014 Jun 16;5:292. doi: 10.3389/fimmu.2014.00292. eCollection 2014.

8.

Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells.

Ghamlouch H, Ouled-Haddou H, Guyart A, Regnier A, Trudel S, Claisse JF, Fuentes V, Royer B, Marolleau JP, Gubler B.

Immunol Cell Biol. 2014 Aug;92(7):591-604. doi: 10.1038/icb.2014.37. Epub 2014 May 6.

9.

Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.

Marcq I, Nyga R, Cartier F, Amrathlal RS, Ossart C, Ouled-Haddou H, Ghamlouch H, Galmiche A, Chatelain D, Lamotte L, Debuysscher V, Fuentes V, Nguyen-Khac E, Regimbeau JM, Marolleau JP, Latour S, Bouhlal H.

PLoS One. 2013 Dec 20;8(12):e82918. doi: 10.1371/journal.pone.0082918. eCollection 2013.

10.

Characterization of a new V gene replacement in the absence of activation-induced cytidine deaminase and its contribution to human B-cell receptor diversity.

Ouled-Haddou H, Ghamlouch H, Regnier A, Trudel S, Herent D, Lefranc MP, Marolleau JP, Gubler B.

Immunology. 2014 Feb;141(2):268-75. doi: 10.1111/imm.12192.

11.

A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.

Ghamlouch H, Ouled-Haddou H, Damaj G, Royer B, Gubler B, Marolleau JP.

PLoS One. 2013;8(3):e60370. doi: 10.1371/journal.pone.0060370. Epub 2013 Mar 26.

12.

MR1B, a natural spliced isoform of the MHC-related 1 protein, is expressed as homodimers at the cell surface and activates MAIT cells.

Lion J, Debuysscher V, Wlodarczyk A, Hodroge A, Serriari NE, Choteau L, Ouled-haddou H, Plistat M, Lassoued K, Lantz O, Treiner E.

Eur J Immunol. 2013 May;43(5):1363-73. doi: 10.1002/eji.201242461.

Supplemental Content

Loading ...
Support Center